GeneCare provides the full range of clinical genetic testing services.
Prenatal Chromosomal, Fetal Anomaly and Perinatal Risk Screening
Maternal AFP and freeBeta Screening Test (13w 4d - 22w 6d)
      PamphletSpanish Pamphlet - MSAFP and freeBeta
Detailed Information
FreeBeta/PAPP-A Screening (9w 0d - 13w 6d)
  Pamphlet
Detailed Information
Press Release 10/29/03
Combined FreeBeta/PAPP-A/Nuchal Translucency Nasal Bone Prenatal Screening Test (11w 0d - 13w 6d)
Detailed Information
      Normal Nuchal Translucency Image
Official Fetal Medicine Foundation (FMF) Nuchal Translucency (NT) and Nasal Bone Certificate Course
** If you have an FMF-NT Certificate, please send us a copy of your certificate and we will beglad to refer First Trimester patients.
** To find a Center providing FMF NT Certificate First Trimester Screening near you, pleasecall or e-mail us at (800) 277-4363 or info@genecare.com.
Amniocentesis & CVS
PamphletPamphlet - Spanish
      Early Amnio
 CVS
Chromosome Analysis
Information on Rh, ABO, Duffy, Kell, Kidd, MN and *Platelet DNA Analysis
*(Neonatal Alloimmune Thrombocytopenia Purpura)
      Pamphlet
      Details
Information on Hereditary Hemochromatosis Testing
Information on Male Infertility Testing
Information on Inherited Venous Thrombosis: Factor V and Prothrombin (Factor II) Testing
Prenatal Genetic Diagnosis
High Resolution Ultrasound
DNA Testing
Genetic Counseling
Bone Marrow, Leukemic Blood and Solid Tumor Analysis
Postnatal Chromosomal Analysis
FISH Chromosomal Analysis
Pamphlet
ONTD (Open Neural Tube Defects), AFAFP & AChE Information
Links To More Resources and Special Interest Organizations
CHROMOSOME ANALYSES- Average Turnaround
- Amniotic Fluid - 7 days
- Routine Bloods - 6 days
- STAT Bloods - 2 days
- Bone Marrow - 4 days
- Abortus or Skin - 8 days
BIOCHEMICAL ANALYSES
- Tay Sachs
- B-Thalassemia
- Alpha Thalassemia
- Sickle Cell Anemia
- Metabolic Disorders
PRENATAL SCREENING *AFP/freeBeta (13 wk 4 d - 22 wk 3 d)
        *freeBeta/PAPP-A (9 wk 0 d - 13 wk 6 d)
- 98% ONTD Detection
- 80% Down Syndrome Detection
- 70% Trisomy 18 Detection
- Fingerstick Blood Collection
        *Ultrascreen- Combined freeBeta/PAPP-A/Nuchal Translucency (11 wk 0 d - 13 wk 6 d)
- 68% Down Syndrome Detection
- 90% Trisomy 18 Detection
- USA - National FMF Nuchal Translucency and Nasal Bone Standard
- Earliest and safest prenatal screening test
- 91% Down Syndrome Detection
- 97% Trisomy 18 Detection
        *Ultrascreen with Absent Nasal Bone
- 97% Down syndrome Detection
- 98% Trisomy-18 Detection
DNA ANALYSES ( All clinical tests, e.g.)
Cystic Fibrosis - 4 days
- Fragile X
- Tay Sachs and other Jewish Disorders
- Paternity
- All Other Available Clinical Genetic Tests
GENETIC COUNSELING/CONSULTS
- Prenatal Dx and Amniocentesis
- High Resolution Fetal Ultrasound
- Reproductive Losses
- Family History of Genetic Disorders
- Drug and/or Alcohol Abuse
- Exposure to Toxic Materials or Infections
- Consults are provided 24 hours/day, 365 days/year.
SPECIAL SERVICES FROM GENECARE
CVS, Early Amniocentesis (EA), and Amniocentesis
GeneCare offers CVS at 10-14 weeks Early Amniocentesis at 12-14 weeks LMP detects >99% detection of open neural tube defects (ONTD) by AChE (acetylcholinesterase) testing. We provide results in 5 to 14 days from receipt of sample, with a 7 day average turnaround time. We have achieved the fastest turnaround time available through use of sophisticated state-of-the-art technology and computer generated chromosomal analysis. The use of this technology allows us to offer unsurpassed results we maintain the highest standard for chromosomal analysis including in situ clonal analysis of 15 high resolution chromosome banded metaphases and analysis of 2 karyotypes. Additional cells are counted, chromosomes analyzed, and special techniques including FISH employed as needed for each type of tissue and chromosome study.
RESULT REPORTING
GeneCare promptly reports results in a manner chosen by the practices we serve. These results may be telephoned, faxed, and/or mailed. All abnormal results are routinely telephoned to the designated contact by one of GeneCare's medical staff.
LICENSURE AND ACCREDITATION
GeneCare Medical Genetics Center is fully licensed and accredited by the following agencies:
         Clinical Laboratories Improvement Act (CLIA)
         College of American Pathologist (CAP)
         States of NY, PA, FL, CT, MD, & NC
GeneCare is Medicaid certified in over 35 states.
BILLING & CONTRACTS
Billing can be customized to meet your needs. We can bill practices, patient insurance, HMOs, TriCare, or Medicaid in most states. Call (866) 485-3336 for references from physicians, hospitals, HMOs, and military bases.FDA APPROVAL FOR PRENATAL SCREENING AND DNA TEST
These tests were developed and their performance characteristics determined by GeneCare (DNA). They have not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. These tests are used for clinical purposes. They should not be regarded as research. The laboratory is regulated under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to perform high complexity clinical testing. All screening tests for genetic disease are considered investigational in accordance with the New York State Department of Health.
CONTINUING EDUCATION
GeneCare provides continuing education through periodic technical bulletins, literature references and rounds or visits. GeneCare also provides training programs at its North Carolina facility for clinicians interested in developing clinical programs. Our nurse genetic counselors and medical geneticists are available to travel to your office to provide continuing education as needed. Contact us for specific requests.
[About GeneCare] [Paternity Testing] [Physician Info] [Patient Info] [Conferences] [What's New?] [Awards]
[QuadInhibin][Employment Opportunities] [Contact Us] [Purchase Books] [Privacy Statement]
[Site Index]
Last modified: February 11, 2005 01:45 PM© 2003 GeneCare, All Rights Reserved.